Literature DB >> 31340990

Recovery of Gram-Negative Bacteria from Aerobic Blood Culture Bottles Containing Antibiotic Binding Resins after Exposure to β-Lactam and Fluoroquinolone Concentrations.

Iris H Chen1, David P Nicolau1, Joseph L Kuti2.   

Abstract

Blood culture bottles containing antibiotic binding resins are routinely used to minimize artificial sterilization in the presence of antibiotics. However, the resin binding kinetics can differ between antibiotics and concentrations. This study assessed the impact of clinically meaningful peak, midpoint, and trough concentrations of meropenem, imipenem, cefepime, cefazolin, levofloxacin, and piperacillin-tazobactam on the recovery of Pseudomonas aeruginosa, Escherichia coli, and Klebsiella pneumoniae from resin-containing BacT/Alert FA Plus and Bactec Aerobic/F blood culture bottles. P. aeruginosa-inoculated bottles alarmed positive in 4/20 (20%), 16/20 (80%), and 20/20 (100%) of those with peak, midpoint, and trough concentrations of antipseudomonal agents, respectively (P ≤ 0.001). E. coli was recovered from 8/24 (33%), 11/24 (46%), and 14/24 (58%) of bottles with peak, midpoint, and trough concentrations, respectively (P = 0.221). K. pneumoniae was recovered from 8/16 (50%) at all concentrations of the studied antibiotics (P = 1.0). BacT/Alert and Bactec bottles inoculated with antibiotics and P. aeruginosa had similar times to detection (TTD) (P = 0.352); however, antibiotic-containing BacT/Alert bottles had a shorter TTD compared with antibiotic-containing Bactec bottles for E. coli (P = 0.026) and K. pneumoniae (P ≤ 0.001). Pathogen recovery in BacT/Alert FA Plus and Bactec Aerobic/F blood culture bottles containing antibiotic binding resins was greatly reduced in the presence of antibiotics, especially at higher concentrations. These data support the practice of drawing blood cultures immediately before an antibiotic dose to maximize the chances of pathogen recovery.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae; antimicrobial stewardship; bacteremia; carbapenem; cephalosporin; levofloxacin; piperacillin

Year:  2019        PMID: 31340990      PMCID: PMC6760962          DOI: 10.1128/JCM.00849-19

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  Use of simulated blood cultures for antibiotic effect on time to detection of the two blood culture systems BacT/ALERT and BACTEC 9240.

Authors:  E F Viganò; E Vasconi; C Agrappi; P Clerici; P Melloni
Journal:  New Microbiol       Date:  2004-07       Impact factor: 2.479

2.  Cost of bloodstream infections.

Authors:  Meredith Kilgore; Stephen Brossette
Journal:  Am J Infect Control       Date:  2008-12       Impact factor: 2.918

3.  The cost of catheter-related bloodstream infections: implications for the value of prevention.

Authors:  Christopher S Hollenbeak
Journal:  J Infus Nurs       Date:  2011 Sep-Oct

4.  Comparison of 2 blood culture media shows significant differences in bacterial recovery for patients on antimicrobial therapy.

Authors:  Rebecca Zadroga; David N Williams; Richard Gottschall; Kevan Hanson; Vickie Nordberg; Marcia Deike; Mike Kuskowski; Lisa Carlson; David P Nicolau; Christina Sutherland; Glen T Hansen
Journal:  Clin Infect Dis       Date:  2012-12-07       Impact factor: 9.079

5.  Optimization of meropenem dosage in the critically ill population based on renal function.

Authors:  Jared L Crandon; Robert E Ariano; Sheryl A Zelenitsky; Anthony M Nicasio; Joseph L Kuti; David P Nicolau
Journal:  Intensive Care Med       Date:  2010-12-07       Impact factor: 17.440

6.  Comparison of BACTEC PLUS blood culture media to BacT/Alert FA blood culture media for detection of bacterial pathogens in samples containing therapeutic levels of antibiotics.

Authors:  Diane Flayhart; Anita P Borek; Teresa Wakefield; James Dick; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2006-12-13       Impact factor: 5.948

7.  Population pharmacokinetics of high-dose, prolonged-infusion cefepime in adult critically ill patients with ventilator-associated pneumonia.

Authors:  Anthony M Nicasio; Robert E Ariano; Sheryl A Zelenitsky; Aryun Kim; Jared L Crandon; Joseph L Kuti; David P Nicolau
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

8.  Relationship between fluoroquinolone area under the curve: minimum inhibitory concentration ratio and the probability of eradication of the infecting pathogen, in patients with nosocomial pneumonia.

Authors:  George L Drusano; Sandra L Preston; Cynthia Fowler; Michael Corrado; Barbara Weisinger; James Kahn
Journal:  J Infect Dis       Date:  2004-04-16       Impact factor: 5.226

Review 9.  Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe.

Authors:  M Goto; M N Al-Hasan
Journal:  Clin Microbiol Infect       Date:  2013-03-08       Impact factor: 8.067

10.  Population pharmacokinetics and pharmacodynamics of continuous versus short-term infusion of imipenem-cilastatin in critically ill patients in a randomized, controlled trial.

Authors:  Samir G Sakka; Anna K Glauner; Jürgen B Bulitta; Martina Kinzig-Schippers; Wolfgang Pfister; George L Drusano; Fritz Sörgel
Journal:  Antimicrob Agents Chemother       Date:  2007-07-09       Impact factor: 5.191

View more
  3 in total

1.  Effect of Clinically Meaningful Antibiotic Concentrations on Recovery of Escherichia coli and Klebsiella pneumoniae Isolates from Anaerobic Blood Culture Bottles with and without Antibiotic Binding Resins.

Authors:  Iris H Chen; David P Nicolau; Joseph L Kuti
Journal:  J Clin Microbiol       Date:  2019-11-22       Impact factor: 5.948

Review 2.  New Microbiological Techniques for the Diagnosis of Bacterial Infections and Sepsis in ICU Including Point of Care.

Authors:  Anna Maria Peri; Adam Stewart; Anna Hume; Adam Irwin; Patrick N A Harris
Journal:  Curr Infect Dis Rep       Date:  2021-06-16       Impact factor: 3.725

Review 3.  Modern Blood Culture: Management Decisions and Method Options.

Authors:  Mark D Gonzalez; Timothy Chao; Matthew A Pettengill
Journal:  Clin Lab Med       Date:  2020-09-19       Impact factor: 1.935

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.